Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

T Cell Types and Functions

T Cell Types and Functions

When T cells with CD4 markers are activated, they give rise to two types of effector cells: helper T cells and regulatory T cells. Meanwhile, T cells with CD8 markers differentiate into effector cytotoxic T cells. The differentiation of CD4 T cells into helper T cell subsets, such as Th1, Th2, and Th17 cells, is dependent on the antigen type, antigen-presenting cell, and regulatory cytokines.
Th1 cells stimulate dendritic cells to express necessary co-stimulatory molecules on their surfaces for...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Pyruvate kinase muscle 2 (PKM2) promotes CD4 T cell survival by regulating pyruvate oxidation during homeostasis and expansion.

Science advances·2026

Same author

The IBEX knowledge-base a community resource enabling adoption and development of immunofluorescence imaging methods.

eLife·2026

Same author

IL-7 promotes the formation of DNA double strand breaks and DNA repair in murine pro-B cells.

Frontiers in immunology·2025

Same author

The IBEX Knowledge-Base: A central resource for multiplexed imaging techniques.

PLoS biology·2025

Same author

Prior SARS-CoV-2 infection affects adaptive immune responses to Omicron BA.4/BA.5 mRNA booster.

The Journal of allergy and clinical immunology·2025

Same author

A lysosomal-targeted switchable fluorescent probe for the detection of peroxynitrite in living tumor cells and in vivo.

Talanta·2025

Same journal

The multifaceted role of acetamide derivative of chalcone: Anti-inflammatory action and impact on osteoclastogenesis, insights on NF-κB and MAPK pathway.

Cytokine·2026

Same journal

Icariin alleviates ovariectomy-induced osteoporosis by promoting M2 macrophage polarization and suppressing osteoclast activation.

Cytokine·2026

Same journal

Single-cell profiling of the immune landscape at the maternal-fetal interface in unexplained recurrent miscarriage.

Cytokine·2026

Same journal

EGFR as a context-dependent modulator of endothelial inflammation: A systematic review.

Cytokine·2026

Same journal

Harnessing the Power of IL-12: Revolutionizing Cancer Therapy with Combinatorial Strategies.

Cytokine·2026

Same journal

Corrigendum to "CCL17 and CCL19 are markers of disease progression in alveolar echinococcosis" [Cytokine 181 (2024) 156669].

Cytokine·2026

See all related articles

Search research articles

Related Experiment Video

Updated: Aug 26, 2025

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

IL-7: Comprehensive review.

Hila Winer¹, Gisele O L Rodrigues¹, Julie A Hixon¹

¹National Cancer Institute, National Institutes of Health, Frederick, MD, USA.

|October 6, 2022

Summary

This summary is machine-generated.

Interleukin-7 (IL-7) is crucial for lymphoid cell development and survival. Dysregulation of the IL-7 pathway is implicated in immunodeficiency, autoimmune diseases, and leukemia, with therapeutic strategies targeting this pathway under investigation.

More Related Videos

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

Published on: March 3, 2023

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Related Experiment Videos

Last Updated: Aug 26, 2025

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Evaluation of the In vivo Antitumor Activity of Polyanhydride IL-1α Nanoparticles

Published on: June 28, 2021

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

A Strategy for the Study of IL-9-Producing Lymphoid Cells in the Nippostrongylus brasiliensis Infection Model

Published on: March 3, 2023

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Ex vivo Expansion of Tumor-reactive T Cells by Means of Bryostatin 1/Ionomycin and the Common Gamma Chain Cytokines Formulation

Published on: January 14, 2011

Area of Science:

Immunology
Molecular Biology
Genetics

Background:

Interleukin-7 (IL-7) is a cytokine essential for lymphoid cell development and survival.
IL-7 exerts its functions by binding to Type I cytokine receptors, specifically the IL-7 receptor alpha (IL-7R) and gamma c (γc) chains.
The IL-7 pathway involves complex signal transduction cascades, including JAK/STAT and PI3K/AKT pathways.

Purpose of the Study:

To provide a comprehensive overview of Interleukin-7 (IL-7), its structure, regulation, and receptor signaling.
To elucidate the critical role of IL-7 in lymphocyte development and homeostasis.
To explore the implications of IL-7 pathway abnormalities in various diseases and potential therapeutic interventions.

Main Methods:

Review of existing literature on IL-7, its receptors, and signaling pathways.
Analysis of genomic architecture and protein structure data for IL-7 and its receptor components.
Examination of clinical applications and therapeutic strategies targeting the IL-7 pathway.

Main Results:

IL-7 is a 152 amino acid peptide produced by stromal cells, with its production regulated by factors like IFNγ.
The IL-7 receptor complex signals through JAK/STAT and other pathways, crucial for lymphocyte survival and development.
Deficiencies in the IL-7 pathway lead to severe combined immunodeficiency, while excessive signaling is linked to autoimmune diseases and leukemia.

Conclusions:

The IL-7 pathway is fundamental for immune system function, impacting lymphocyte development and homeostasis.
Aberrations in IL-7 signaling contribute to a spectrum of diseases, including immunodeficiency, autoimmunity, and cancer.
Targeting the IL-7 pathway with therapeutic agents, such as monoclonal antibodies and signal transduction inhibitors, shows promise for treating these conditions.